|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities | |||||
| Depreciation and amortization | |||||
| Non-cash lease expense | |||||
| Issuance of common stock for services | |||||
| Stock-based compensation | |||||
| Change in foreign currency translation | |||||
| Gain on legal settlement | |||||
| Accrued interest added to secured promissory note | |||||
| Inventory reserve | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Other accounts receivable | |||||
| Unbilled accounts receivable | |||||
| Inventory | |||||
| Prepaid expense and other assets | |||||
| Contract assets | |||||
| Prepaid expenses | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Contract loss provision | |||||
| Accrued bonuses | |||||
| Accrued contract loss provision | |||||
| Accrued legal settlement | |||||
| Unearned Revenue | |||||
| Other Liabilities | |||||
| Operating lease liability | |||||
| Net cash used in Operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Purchases of property and equipment | |||||
| Purchases of marketable securities | |||||
| Proceeds from marketable securities | |||||
| Increase in intangible assets | |||||
| Proceeds from the sale of investments | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Proceeds from the exercise of options and warrants | |||||
| Repayments on note payable | |||||
| Repayments on financing liability | |||||
| Proceeds from secured promissory note | |||||
| Proceeds from the exercise of options | |||||
| Gross proceeds from the issuance of common stock | |||||
| Net proceeds from the sale of common stock | |||||
| Issuance costs related to sales of common stock | |||||
| Warrant repurchase | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rates on cash | |||||
| Net (decrease) increase in cash | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
| Supplemental cash flow disclosures | |||||
| Cash paid for interest | |||||
| Cash paid for taxes | |||||
| Cash paid for taxes | |||||
| Supplemental disclosure operating, investing and financing activities | |||||
| Change in unrealized loss on AFS investment securities | |||||
| Transfers of investment securities from AFS to HTM | |||||
| Amortization of AFS investment securities unrealized loss in AOCI into interest income as yield adjustment | |||||
| Amortization of unrealized loss into interest income as yield adjustment | |||||
| Cashless stock option exercises | |||||
| Equipment purchase in accounts payable | |||||
| Initial right-of-use asset and liability | |||||
| Transfers of investments securities from AFS to HTM | |||||
| Reclassification of inventory to property and equipment | |||||
| Issuance of restricted common stock | |||||
| Equipment financed with a note payable | |||||
| Accrued expense settled with shares of common stock | |||||
| Prepaid insurance financed | |||||
| Deemed dividend on warrant modification | |||||
Loading...